financingResolve Biosciences secures US$71m in fundingLatest NewsMolecular cartography company Resolve Biosciences has raised $71m in series B funding co-led by Patient Square Capital, EDBI, Alafi Capital and NRW.BANK as well as other existing investors. Read more 24 October 2022 https://european-biotechnology.com/wp-content/uploads/2024/04/Bildschirmfoto_2022-10-25_um_10.26.25.png 389 606 Thomas Gabrielczyk /wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.png Thomas Gabrielczyk2022-10-24 10:20:002024-07-16 12:34:47Resolve Biosciences secures US$71m in funding
